Innoviva Inc (INVA)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
2019 (31 gru 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 179 722 | 213 921 | 265 854 | 224 402 | 157 288 |
| Aktywa razem | w tys. USD | 1 243 510 | 1 231 500 | 926 395 | 999 570 | 724 826 |
| ROA | 14,45% | 17,37% | 28,70% | 22,45% | 21,70% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $179 722K ÷ $1 243 510K
= 14,45%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Innoviva Inc
INVA
14,45%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Collegium Pharmaceutical Inc
COLL
4,21%
Dynavax Technologies Corp.
DVAX
-0,64%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Medifast Inc
MED
32,08%
Myriad Genetics, Inc.
MYGN
-22,97%
Xencor Inc
XNCR
-13,23%